FLT1 and type 2 diabetes mellitus: Removing the inhibitory effect of VEGF165b bound to VEGFR1 allowed VEGFR1-STAT3 signaling activation that resulted in increased angiogenesis and perfusion recovery in T2D-HLI muscle.